DC 欄位 | 值 | 語言 |
dc.contributor | 國立臺灣大學農藝學系 | zh_TW |
dc.contributor.author | Liu, Jen-Pei | en |
dc.creator | Liu, Jen-Pei | - |
dc.date | 2006 | - |
dc.date.accessioned | 2006-09-28T09:58:42Z | - |
dc.date.accessioned | 2018-07-11T01:16:16Z | - |
dc.date.available | 2006-09-28T09:58:42Z | - |
dc.date.available | 2018-07-11T01:16:16Z | - |
dc.date.issued | 2006 | - |
dc.identifier | 246246/2006092815540130 | zh_TW |
dc.identifier.uri | http://ntur.lib.ntu.edu.tw//handle/246246/2006092815540130 | - |
dc.description.abstract | Characterization of Cancer Trials
Patient population – life-threatening and irreversible
Treatments – cytotoxic agents:
No efficacy at lower doses but with severe immunosuppression, hepatic, renal, and cardiac toxicity
Efficacious at high doses but with possible fatal or life-threatening AEs | en |
dc.format | application/ppt | zh_TW |
dc.format.extent | 641024 bytes | - |
dc.format.mimetype | application/vnd.ms-powerpoint | - |
dc.language | zh-TW | zh_TW |
dc.language.iso | zh_TW | - |
dc.publisher | 臺北市:國立臺灣大學農藝學系 | zh_TW |
dc.source | http://personal.agron.ntu.edu.tw/jpliu/data/statistical_methods_for_biotechnolgy_products_ii/94/cancer_clinical_trials.ppt | en |
dc.subject.classification | [SDGs]SDG3 | - |
dc.title | Statistical Methods for Biotechnology Products II-Phase I and II Cancer Clinical Trials | en |
dc.type | learning object | en |
dc.identifier.uri.fulltext | http://ntur.lib.ntu.edu.tw/bitstream/246246/2006092815540130/1/cancer_clinical_trials.ppt | - |
item.fulltext | with fulltext | - |
item.openairetype | learning object | - |
item.languageiso639-1 | zh_TW | - |
item.openairecristype | http://purl.org/coar/resource_type/c_e059 | - |
item.grantfulltext | open | - |
item.cerifentitytype | Publications | - |
crisitem.author.orcid | 0000-0002-9565-1812 | - |
顯示於: | 農藝學系
|